May 17, 2024 02:19 PM EDTUpdated 02:33 PM
Pharma
Coronavirus

Mod­er­na scores Eu­ro­pean vic­to­ry over Pfiz­er and BioN­Tech in mR­NA patent bat­tle

Zachary Brennan

Senior Editor

The Eu­ro­pean Patent Of­fice on Thurs­day hand­ed a win to Mod­er­na in a long-run­ning patent bat­tle with Pfiz­er and BioN­Tech over cer­tain com­po­nents of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times